Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S ALEXANDER

Showing results (1251-1260 of 1,467) with videos related to

Pageof 147
Sort By:
Molecular Therapy. Advances|July 12, 2026
Antimetabolites synergize with non-genotoxic antibody drug conjugate conditioning in hematopoietic stem cell lentiviral gene therapyJennifer Okalova, Jordan S Alexander, Seema R Patel, et al.
British Journal of Pharmacology|May 20, 2015
IL-1β reduces tonic contraction of mesenteric lymphatic muscle cells, with the involvement of cycloxygenase-2 and prostaglandin E2M Al-Kofahi, F Becker, F N E Gavins, et al.
New Zealand Veterinary Journal|April 15, 2016
Dermatomycosis caused by Paranannizziopsis australasiensis in five tuatara (Sphenodon punctatus) and a coastal bearded dragon (Pogona barbata) in a zoological collection in New ZealandN J Masters, S Alexander, B Jackson, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2001
The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivoJ G Zhang, D Metcalf, S Rakar, et al.
Nature|June 26, 1997
A family of cytokine-inducible inhibitors of signallingR Starr, T A Willson, E M Viney, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2005
Suppressor of cytokine signaling (SOCS)-5 is a potential negative regulator of epidermal growth factor signalingSandra E Nicholson, Donald Metcalf, Naomi S Sprigg, et al.
Journal of Thrombosis and Haemostasis : JTH|March 8, 2025
A glycoprotein VI signaling defect in newly formed platelets generated in stress thrombopoiesisStephanie R Hyslop, Jason Corbin, Pradnya Gangatirkar, et al.
The Journal of Infectious Diseases|January 6, 2005
Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapyP Richard Harrigan, Robert S Hogg, Winnie W Y Dong, et al.
Cancer Research|December 28, 2012
Epigenetic regulator Smchd1 functions as a tumor suppressorHuei San Leong, Kelan Chen, Yifang Hu, et al.
The Journal of Clinical Investigation|May 20, 2006
SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritisPeter K K Wong, Paul J Egan, Ben A Croker, et al.
Pageof 147

Showing results (1251-1260 of 1,467) with videos related to

Sort By:
Pageof 147
Molecular Therapy. Advances|July 12, 2026
Antimetabolites synergize with non-genotoxic antibody drug conjugate conditioning in hematopoietic stem cell lentiviral gene therapyJennifer Okalova, Jordan S Alexander, Seema R Patel, et al.
British Journal of Pharmacology|May 20, 2015
IL-1β reduces tonic contraction of mesenteric lymphatic muscle cells, with the involvement of cycloxygenase-2 and prostaglandin E2M Al-Kofahi, F Becker, F N E Gavins, et al.
New Zealand Veterinary Journal|April 15, 2016
Dermatomycosis caused by Paranannizziopsis australasiensis in five tuatara (Sphenodon punctatus) and a coastal bearded dragon (Pogona barbata) in a zoological collection in New ZealandN J Masters, S Alexander, B Jackson, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 19, 2001
The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivoJ G Zhang, D Metcalf, S Rakar, et al.
Nature|June 26, 1997
A family of cytokine-inducible inhibitors of signallingR Starr, T A Willson, E M Viney, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 8, 2005
Suppressor of cytokine signaling (SOCS)-5 is a potential negative regulator of epidermal growth factor signalingSandra E Nicholson, Donald Metcalf, Naomi S Sprigg, et al.
Journal of Thrombosis and Haemostasis : JTH|March 8, 2025
A glycoprotein VI signaling defect in newly formed platelets generated in stress thrombopoiesisStephanie R Hyslop, Jason Corbin, Pradnya Gangatirkar, et al.
The Journal of Infectious Diseases|January 6, 2005
Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapyP Richard Harrigan, Robert S Hogg, Winnie W Y Dong, et al.
Cancer Research|December 28, 2012
Epigenetic regulator Smchd1 functions as a tumor suppressorHuei San Leong, Kelan Chen, Yifang Hu, et al.
The Journal of Clinical Investigation|May 20, 2006
SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritisPeter K K Wong, Paul J Egan, Ben A Croker, et al.
Pageof 147